KATHLEEN AFRICANO: Open Payments
NPI 1659300416 · DARIEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,306 in 146 payments from 13 companies in 2025. Trend: 2023 $1,263 · 2024 $2,332 · 2025 $3,306
Food & beverage: $3,111Education: $195
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $481 |
| ABBVIE INC. | 23 | $460 |
| Neurocrine BioSciences, Inc. | 16 | $449 |
| Teva Pharmaceuticals USA, Inc. | 12 | $376 |
| Otsuka America Pharmaceutical, Inc. | 17 | $352 |
| Lundbeck LLC | 18 | $284 |
| Vanda Pharmaceuticals Inc. | 14 | $266 |
| E.R. Squibb & Sons, L.L.C. | 21 | $260 |
| Axsome Therapeutics, Inc. | 2 | $149 |
| Janssen Pharmaceuticals, Inc | 4 | $124 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, REXULTI, FANAPT, COBENFY, ABILIFY ASIMTUFII, Auvelity.
Industry payments across CT — which companies pay providers there.
